Literature DB >> 11227020

Current problems of amebiasis in Japan and recent advances in amebiasis research.

T Nozaki1.   

Abstract

Amebiasis is epidemic in two major populations in Japan: male homosexuals and institutionalized people. Currently available diagnostic, chemotherapeutic, and prophylactic measures and their problems are discussed. Recent advances in basic research on amebiasis are also described with new findings of unique metabolisms and intracellular structures and organization. Discoveries and analyses of the unique features presented by this parasitic protist help in our elucidation of the pathogenic mechanisms of the parasite and may eventually lead to the development of new drugs and vaccines against amebiasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11227020

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

Review 1.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Comparison of serine-rich protein genes of Entamoeba histolytica isolates obtained from institutions for the mentally retarded in Kanagawa and Shizuoka Prefectures, Japan.

Authors:  Yong-Feng Fu; Kouichi Nagakura; Xun-Jia Cheng; Hiroshi Tachibana
Journal:  Parasitol Res       Date:  2010-06-17       Impact factor: 2.289

3.  Molecular evidence for person-to-person transmission of a novel subtype in Giardia duodenalis assemblage B at the rehabilitation institution for developmentally disabled people.

Authors:  Niichiro Abe; Isao Teramoto
Journal:  Parasitol Res       Date:  2011-07-23       Impact factor: 2.289

4.  Risk factors for intestinal invasive amebiasis in Japan, 2003-2009.

Authors:  Naoyoshi Nagata; Takuro Shimbo; Junichi Akiyama; Ryo Nakashima; So Nishimura; Tomoyuki Yada; Koji Watanabe; Shinichi Oka; Naomi Uemura
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.